A judge blamed “deliberate indifference” for the illness of a man held by immigration officials. Across the country, several ...
No advanced therapies approved to treat ColdU and SD—diseases of misery that dramatically impact all aspects of patient lifeBarzolvolimab is the ...
AZ Animals US on MSN
Got Flea Bites? How to Tell If the Itchy Red Marks Aren’t Mosquitoes
I remember, as a young child in the South, walking onto a carpet and having my feet covered in little black dots. At first, I ...
Similar to humans, cats and dogs face the risk of frostbite and hypothermia if exposed to extreme cold for prolonged periods, ...
Women are increasingly turning to anabolic steroids to achieve fitness goals, but face severe health risks. Experts warn of ...
Zevaskyn, the first gene therapy for recessive dystrophic epidermolysis bullosa, showed significant wound healing in phase 3 ...
The U.S. commercial launch of LYMPHIR (denileukin diftitox-cxdl), a novel cancer immunotherapy for adults with relapsed or ...
Explore the rise of adult-onset allergies, their causes, symptoms, and effective management strategies in modern urban ...
Best air purifiers under 20K for home or office use: What to buy now as severe smog chokes Delhi-NCR
Air purifiers with HEPA filters, higher CADR and correct room-size coverage can cut indoor PM2.5, ease breathing trouble and ...
Skin conditions such as eczema and psoriasis often worsen in cold weather due to low humidity and indoor heating, leading to ...
Results from the GLISTEN study, the largest investigational trial of pruritus in primary biliary cholangitis (PBC), indicate ...
GlobalData on MSN
Mirum to buy Bluejay for up to $820m in rare liver disease push
The deal gives Mirum access to Bluejay’s monoclonal antibody brelovitug, which is currently in Phase III trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results